Literature DB >> 31999063

The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH.

Jeffrey I Zwicker1, Tzu-Fei Wang2, Daniel J DeAngelo3, Mandy N Lauw4,5,6, Jean M Connors7, Anna Falanga8,9, Malgorzata McMasters10, Marc Carrier11.   

Abstract

Venous thromboembolism is a common complication of asparaginase-based chemotherapy regimens for the treatment of acute lymphoblastic leukemia. Thrombosis associated with asparaginase administration poses a number of specific and often clinically challenging management decisions. This review provides guidance on the prevention and treatment of thrombosis associated with asparaginase in adults including discussions on antithrombin repletion, pharmacologic thromboprophylaxis, cerebral venous thrombosis, and therapeutic anticoagulation.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  acute lymphoblastic leukemia; anticoagulation; antithrombin; asparaginase; cerebral venous thrombosis; venous thromboembolism

Mesh：

Substances：

Year:  2020        PMID： 31999063     DOI： 10.1111/jth.14671

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


  6 in total

Review 1.  Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.

Authors:  David O Riley; Jenna M Schlefman; Hans Christoph Vitzthum Von Eckstaedt V; Amy L Morris; Michael K Keng; Firas El Chaer
Journal:  Curr Hematol Malig Rep       Date:  2021-05-12       Impact factor: 3.952

2.  Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.

Authors:  Tzu-Fei Wang; Robert S Makar; Darko Antic; Jerrold H Levy; James D Douketis; Jean M Connors; Marc Carrier; Jeffrey I Zwicker
Journal:  J Thromb Haemost       Date:  2020-12       Impact factor: 5.824

3.  Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia.

Authors:  Brynne Underwood; Qiuhong Zhao; Alison R Walker; Alice S Mims; Sumithira Vasu; Meixiao Long; Tamanna Z Haque; Bradley W Blaser; Nicole R Grieselhuber; Sarah A Wall; Gregory K Behbehani; James S Blachly; Karilyn Larkin; John C Byrd; Ramiro Garzon; Tzu-Fei Wang; Bhavana Bhatnagar
Journal:  Int J Hematol Oncol       Date:  2020-09-04

Review 4.  Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy.

Authors:  Krishna R Juluri; Chloe Siu; Ryan D Cassaday
Journal:  Blood Lymphat Cancer       Date:  2022-05-30

5.  Cerebrovascular manifestations in hematological diseases: an update.

Authors:  José M Ferro; Joana Infante
Journal:  J Neurol       Date:  2021-02-13       Impact factor: 4.849

6.  Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study.

Authors:  Mette Tiedemann Skipper; Cecilie Utke Rank; Kirsten Brunsvig Jarvis; Line Stensig Lynggaard; Liv Andrés-Jensen; Petter Quist-Paulsen; Ruta Semaskeviciene; Helene Hallböök; Ulla Waitiovaara-Kautto; Susanna Ranta; Sonata Trakymiene; Jonas Abrahamsson; Pasi Huttunen; Birgitte Klug Albertsen; Kjeld Schmiegelow; Ruta Tuckuviene
Journal:  EJHaem       Date:  2022-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.